Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer
Technology appraisal guidance
Reference number: TA643
Published:
This appraisal was discussed by the technology appraisal committee on 20 November 2019. The committee’s decision will be released to consultees and commentators once positive CHMP opinion has been granted.